Inventor · disambiguated record
Stuart Travers
Also filed as: TRAVERS STUART
6 granted patents·10 pending applications·78 citations·filing 2005–2023
84Inventor score
Top patents by PatentIndex Score
16 records- 0196US7572784B2Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2005·Granted Aug 11, 2009·38 cites·20 claims
- 0293US9765078B2Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2015·Granted Sep 19, 2017·11 cites·18 claims
- 0392US9102678B2Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2012·Granted Aug 11, 2015·13 cites·20 claims
- 0487US8399659B2Compounds and methods for inhibiting mitotic progressionCLAIBORNE CHRISTOPER F·Filed 2009·Granted Mar 19, 2013·15 cites·37 claims
- 0587US2024083906A1Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2023·Application pending·0 cites
- 0679US10414770B2Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2017·Granted Sep 17, 2019·1 cites·4 claims
- 0777US2022041605A1Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2021·Application pending·0 cites
- 0876US11014928B2Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2019·Granted May 25, 2021·0 cites·4 claims
- 0961US2007185087A1Compounds and methods for inhibiting mitotic progressionMILLENNIUM PHARM INC·Filed 2006·Application pending·0 cites
- 1054US2008234276A1Heterocyclic Triazines as Hypoxic Selective Protein Kinase InhibitorsSENTINEL ONCOLOGY LTD·Filed 2006·Application pending·0 cites
- 1154US2010048540A1Heterocyclic N-Oxides as Hypoxic Selective Protein Kinase InhibitorsSENTINEL ONCOLOGY LTD·Filed 2006·Application pending·0 cites
- 1254US2024287035A1Preparation of a chk1 inhibitor compoundSENTINEL ONCOLOGY LTD·Filed 2022·Application pending·0 cites
- 1353US2024140908A1A pharmaceutical salt of an arylpyrrole derivativeSENTINEL ONCOLOGY LTD·Filed 2021·Application pending·0 cites
- 1453US2024360101A1Pharmaceutical salts of a chk-1 inhibitorSENTINEL ONCOLOGY LTD·Filed 2022·Application pending·0 cites
- 1547US2022348565A1Pharmaceutical compoundsSENTINEL ONCOLOGY LTD·Filed 2020·Application pending·0 cites
- 1645US2009270416A1N-OXIDES OF DIARYLUREA DERIVATIVES AND THEIR USE AS Chk1 INHIBITORS FOR THE TREATMENT OF CANCERSENTINEL ONCOLOGY LTD·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stuart Travers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →